ArticleBlood advances2025

Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma.

Samer Al Hadidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.